Zyhcg
Developed to mitigate ovarian and testicular hormone deficits to support fertility pathways and target ovulation induction.
- Categories
- Women's Health · Hormone Therapy
- Active ingredient
- Human Chorionic Gonadotropin
- Route
- Intramuscular use
- Form
- Vial
- Strengths
- 5000iu
Prescription and consultation requirements for Zyhcg vary by destination and are determined by the fulfilment partner.
Zyhcg details
- Conditions
- Ovulation Induction · Hypogonadotropic Hypogonadism
- Alternative names
- human chorionic gonadotropin
- Therapeutic class
- Gonadotropin
- Pharmacological class
- Ovarian Stimulant
- Contraindications
- prostate cancer; precocious puberty; unexplained vaginal bleeding; ovarian cysts
- Minor side effects
- headache; fatigue; irritability
- Moderate side effects
- fluid retention; breast tenderness; depression
- Serious side effects
- ovarian hyperstimulation syndrome, requires immediate medical attention
- Dosage forms
- Vial
- Administration route
- Intramuscular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Zydus Cadila
- Onset Time
- 24–48 hours
- Duration
- 2–4 days
- Storage instructions
- Store between 2°C and 8°C. Do not freeze.
- Age restrictions
- Approved for paediatric and adult populations based on indication.
Patient summary
developed to mitigate ovarian and testicular hormone deficits to support fertility pathways and target ovulation induction.
Mechanism of action
Acts as an LH analog, stimulating ovulation in women and encouraging testosterone synthesis in men.
Pregnancy and breastfeeding
TGA Category X: Highly contraindicated. No benefit during pregnancy. Breastfeeding: Consult a doctor.